share_log

bioAffinity Technologies | 8-K: CMS Posts Final Payment Determination for bioAffinity Technologies' CyPath® Lung Effective January 2024

SEC announcement ·  Nov 30, 2023 09:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more